The role of axillary lymph node dissection in breast cancer management

被引:39
作者
Noguchi M. [1 ,2 ]
Miwa K. [2 ]
Michigishi T. [3 ]
Yokoyama K. [3 ]
Nishijima H. [4 ]
Takanaka T. [4 ]
Kawashima H. [4 ]
Nakamura S. [5 ]
Kanno H. [5 ]
Nonomura A. [6 ]
机构
[1] Department of Surgery (II), Operation Center, Kanazawa University Hospital, Kanazawa 920, Takara-machi
[2] Department of Surgery (II), Kanazawa University Hospital
[3] Department of Nuclear Medicine, Kanazawa University Hospital
[4] Department of Radiology, Kanazawa University Hospital
[5] Department of Internal Medicine (III), Kanazawa University Hospital
[6] Department of Pathology Section, Kanazawa University Hospital
关键词
Axillary dissection; Axillary metastases; Breast cancer; Sentinel lymph node biopsy;
D O I
10.1007/BF02967068
中图分类号
学科分类号
摘要
Although it is generally accepted that axillary dissection provides no survival advantage in patients with breast cancer, it is commonly regarded as a reliable method of assessing nodal status and treating regional disease. However, it is time to consider eliminating routine axillary dissection in patients who are clinically nodenegative. A sentinel lymph node biopsy may assess axillary nodal status while obviating a full axillary dissection. At present, axillary dissection remains the standard approach for the surgical management of all patients with invasive carcinoma of the breast, regardless of tumor size or patient age, though it is unnecessary for patients with small intraductal carcinomas.
引用
收藏
页码:143 / 153
页数:10
相关论文
共 130 条
[21]  
White R.E., Vezeridis M.P., Konstadoulakis M., Et al., Therapeutic options and results for the management of minimally invasive carcinoma of the breast
[22]  
Influence of axillary dissection for treatment of T1a and T1b lesions, J Am Coll Surg, 183, pp. 32-582, (1996)
[23]  
Haffty B.G., McKhann C., Beinfield M., Et al., Breast conservation therapy without axillary dissection, Arch Surg, 128, pp. 32-1319, (1993)
[24]  
Dewar J.A., Sarrazin D., Benhamou E., Et al., Management of the axilla in conservatively treated breast cancer
[25]  
592 patients treated at institut gustave-roussy, Int J Radiat Oncol Biol Phys, 13, pp. 32-481, (1987)
[26]  
Ogawa Y., Nishioka A., Hamada N., Et al., Significance of axillary node dissection for patients with breast cancer, Jpn J Breast Cancer, 10, pp. 32-478, (1995)
[27]  
Lythgoe J.P., Palmer M.K., Manchester regional breast study
[28]  
5 and 10 year results, Br J Surg, 69, pp. 32-696, (1982)
[29]  
Cancer research campaign working party: Cancer research campaign (King's/Cambridge) trial for early breast cancer
[30]  
A detailed update at the tenth year, Lancet, 2, pp. 32-60, (1980)